{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:08:02Z","timestamp":1787144882802,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,3,17]],"date-time":"2005-03-17T00:00:00Z","timestamp":1111017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00467-004-1760-1","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T10:25:53Z","timestamp":1110968753000},"page":"811-813","source":"Crossref","is-referenced-by-count":39,"title":["Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression"],"prefix":"10.1007","volume":"20","author":[{"given":"Monika","family":"Edelbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Jungraithmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar Bernd","family":"Zimmerhackl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,17]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s004670050034","volume":"14","author":"Niaudet","year":"2000","unstructured":"Niaudet P (2000) Treatment of lupus nephritis in children. Pediatr Nephrol 14:158\u2013166","journal-title":"Pediatr Nephrol"},{"key":"1760_CR2","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","volume":"46","author":"Houssiau","year":"2000","unstructured":"Houssiau FA, Vasconcelos C, D\u2019Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R (2000) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121\u20132131","journal-title":"Arthritis Rheum"},{"key":"1760_CR3","first-page":"487","volume":"19","author":"Lehman","year":"2001","unstructured":"Lehman TJ (2001) Modern treatment of childhood SLE. Clin Exp Rheumatol 19:487\u2013489","journal-title":"Clin Exp Rheumatol"},{"key":"1760_CR4","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","volume":"125","author":"Strashenko","year":"1980","unstructured":"Strashenko P, Nadler LM, Hardy R, Schlossman SF (1980) Characterization of a human B lymphocyte-specific antigen. J Immunol 125:1678\u20131685","journal-title":"J Immunol"},{"key":"1760_CR5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","volume":"83","author":"Reff","year":"1994","unstructured":"Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, Newman RA, Hanna N, Anderson DR (1994) Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 83:435\u2013445","journal-title":"Blood"},{"key":"1760_CR6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/ar759","volume":"5","author":"Eisenberg","year":"2003","unstructured":"Eisenberg R (2003) SLE\u2014rituximab in lupus. Arthritis Res Ther 5:157\u2013159","journal-title":"Arthritis Res Ther"},{"key":"1760_CR7","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","volume":"46","author":"Leandro","year":"2002","unstructured":"Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA (2002) An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 46:2673\u20132677","journal-title":"Arthritis Rheum"},{"key":"1760_CR8","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","volume":"50","author":"Looney","year":"2004","unstructured":"Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I (2004) B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab. Arthritis Rheum 50:2580\u20132589","journal-title":"Arthritis Rheum"},{"key":"1760_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1600-065X.1999.tb01310.x","volume":"169","author":"Chan","year":"1999","unstructured":"Chan OT, Madaio MP, Shlomchik MJ (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 169:107\u2013121","journal-title":"Immunol Rev"},{"key":"1760_CR10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O","volume":"43","author":"Zonana-Nacach","year":"2000","unstructured":"Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801\u20131808","journal-title":"Arthritis Rheum"},{"key":"1760_CR11","first-page":"275","volume":"15","author":"D","year":"1997","unstructured":"D\u2019Cruz D, Cuadrado MJ, Mujic F, Tungekar MF, Taub N, Lloyd M, Khamashta MA, Hughes GR (1997) Immunosuppressive therapy in lupus nephritis. Clin Exp Rheumatol 15:275\u2013282","journal-title":"Clin Exp Rheumatol"},{"key":"1760_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2004.05.001","volume":"113","author":"Hoffman","year":"2004","unstructured":"Hoffman RW (2004) T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol 113:4\u201313","journal-title":"Clin Immunol"},{"key":"1760_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1191\/0961203302lu235oa","volume":"11","author":"Anand","year":"2002","unstructured":"Anand A, Dean GS, Quereshi K, Isenberg DA, Lydyard PM (2002) Characterization of CD3+ CD4\u2212 CD8\u2212 (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus 11:493\u2013500","journal-title":"Lupus"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1760-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-004-1760-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1760-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:06:33Z","timestamp":1683047193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-004-1760-1"}},"subtitle":["Case report"],"short-title":[],"issued":{"date-parts":[[2005,3,17]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1007\/s00467-004-1760-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,17]]}}}